Literature DB >> 25824436

Feasibility and acceptability of esophageal-directed hypnotherapy for functional heartburn.

M E Riehl1, J E Pandolfino1, O S Palsson1, L Keefer1.   

Abstract

Functional heartburn (FH) is a benign but burdensome condition characterized by painful, burning epigastric sensations in the absence of acid reflux or symptom-reflux correlation. Esophageal hypersensitivity and its psychological counterpart, esophageal hypervigilance (EHv) drive symptom experience. Hypnotherapy (HYP) is an established and preferred intervention for refractory symptoms in functional gastrointestinal disorders (FGIDs) and could be applied to FH. The objective of this study was to determine the feasibility, acceptability, and clinical utility of 7 weekly sessions of esophageal-directed HYP (EHYP) on heartburn symptoms, quality of life, and EHv. Similar to other work in FGIDs and regardless of hypnotizability, there were consistent and significant changes in heartburn symptoms, visceral anxiety, and quality of life and a trend for improvement in catastrophizing. We would recommend EHYP in FH patients who are either non-responsive to medications or who would prefer a lifestyle intervention.
© 2015 International Society for Diseases of the Esophagus.

Entities:  

Keywords:  esophageal hypervigilance; functional heartburn; hypnosis; relaxation

Mesh:

Year:  2015        PMID: 25824436      PMCID: PMC4589470          DOI: 10.1111/dote.12353

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  39 in total

Review 1.  The growing case for hypnosis as adjunctive therapy for functional gastrointestinal disorders.

Authors:  Olafur S Palsson; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

Review 2.  Functional heartburn: definition and management strategies.

Authors:  Frank Zerbib; Stanislas Bruley des Varannes; Mireille Simon; Jean Paul Galmiche
Journal:  Curr Gastroenterol Rep       Date:  2012-06

3.  The clinical global impressions scale: applying a research tool in clinical practice.

Authors:  Joan Busner; Steven D Targum
Journal:  Psychiatry (Edgmont)       Date:  2007-07

4.  Hypnotherapy for selected gastrointestinal disorders.

Authors:  P J Whorwell
Journal:  Dig Dis       Date:  1990       Impact factor: 2.404

5.  Selective-serotonin reuptake inhibitors for the treatment of hypersensitive esophagus.

Authors:  Nikos Viazis; George Karamanolis; Eleni Vienna; Dimitrios G Karamanolis
Journal:  Therap Adv Gastroenterol       Date:  2011-09       Impact factor: 4.409

6.  Openness to absorbing and self-altering experiences ("absorption"), a trait related to hypnotic susceptibility.

Authors:  A Tellegen; G Atkinson
Journal:  J Abnorm Psychol       Date:  1974-06

7.  Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness.

Authors:  Wendy M Gonsalkorale; Lesley A Houghton; Peter J Whorwell
Journal:  Am J Gastroenterol       Date:  2002-04       Impact factor: 10.864

8.  Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study.

Authors:  Nikos Viazis; Anastasia Keyoglou; Alexandros K Kanellopoulos; George Karamanolis; John Vlachogiannakos; Konstantinos Triantafyllou; Spiros D Ladas; Dimitrios G Karamanolis
Journal:  Am J Gastroenterol       Date:  2011-05-31       Impact factor: 10.864

9.  Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial.

Authors:  R E Clouse; P J Lustman; T C Eckert; D M Ferney; L S Griffith
Journal:  Gastroenterology       Date:  1987-04       Impact factor: 22.682

10.  Role of histaminergic neurons in hypnotic modulation of brain processing of visceral perception.

Authors:  S Watanabe; T Hattori; M Kanazawa; M Kano; S Fukudo
Journal:  Neurogastroenterol Motil       Date:  2007-10       Impact factor: 3.598

View more
  16 in total

Review 1.  Diagnosis and Management of Functional Heartburn.

Authors:  Christine Hachem; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2016-01-05       Impact factor: 10.864

Review 2.  The Proton Pump Inhibitor Nonresponder: a Behavioral Approach to Improvement and Wellness.

Authors:  Megan E Riehl; Joan W Chen
Journal:  Curr Gastroenterol Rep       Date:  2018-06-09

3.  Hypnotherapy for Esophageal Disorders.

Authors:  Megan E Riehl; Laurie Keefer
Journal:  Am J Clin Hypn       Date:  2015-07

4.  Treatment of supragastric belching with cognitive behavioral therapy improves quality of life and reduces acid gastroesophageal reflux.

Authors:  E Glasinovic; E Wynter; J Arguero; J Ooi; K Nakagawa; E Yazaki; P Hajek; Clin C Psych; P Woodland; D Sifrim
Journal:  Am J Gastroenterol       Date:  2018-02-20       Impact factor: 10.864

5.  Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel.

Authors:  Rena Yadlapati; Michael F Vaezi; Marcelo F Vela; Stuart J Spechler; Nicholas J Shaheen; Joel Richter; Brian E Lacy; David Katzka; Philip O Katz; Peter J Kahrilas; Prakash C Gyawali; Lauren Gerson; Ronnie Fass; Donald O Castell; Jenna Craft; Luke Hillman; John E Pandolfino
Journal:  Am J Gastroenterol       Date:  2018-04-24       Impact factor: 10.864

Review 6.  Patients with refractory reflux symptoms: What do they have and how should they be managed?

Authors:  P J Kahrilas; L Keefer; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2015-09       Impact factor: 3.598

7.  Low-Dose Tricyclics for Esophageal Hypersensitivity: Is it all Placebo Effect?

Authors:  Laurie Keefer; Peter J Kahrilas
Journal:  Am J Gastroenterol       Date:  2016-02       Impact factor: 10.864

8.  Update on Functional Heartburn.

Authors:  Takahisa Yamasaki; Jessica O'Neil; Ronnie Fass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-12

9.  The Spectrum of Reflux Phenotypes.

Authors:  Lisa B Mahoney; Rachel Rosen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-12

10.  Esophageal hypervigilance is prevalent across gastroesophageal reflux disease presentations.

Authors:  Livia Guadagnoli; Rena Yadlapati; Tiffany Taft; John E Pandolfino; Michael Tye; Laurie Keefer
Journal:  Neurogastroenterol Motil       Date:  2021-01-11       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.